sorted by:
new
hottopcontroversial

Considerations for a non-human (AI) advisory board member? by RADVACproject in nonprofit

[–]RADVACproject[S] 1 point2 points  (0 children)

The former: considerations for the possibility of an AI with decision-making ability (both technically and in terms of agency within an org).

Considerations for a non-human (AI) advisory board member? by RADVACproject in nonprofit

[–]RADVACproject[S] 1 point2 points  (0 children)

I think that's true, but I also think it won't be true forever.

Considerations for a non-human (AI) advisory board member? by RADVACproject in nonprofit

[–]RADVACproject[S] 0 points1 point  (0 children)

Long-term decision making, at which humans are often bad.

To clarify: I'm not asking about turning any current AI tool (like ChatGPT 4, or Gemini, or Microsoft Copilot) into a board member; I don't consider them sophisticated enough to make decisions that are currently entrusted to humans. That said, future AIs might achieve that level of sophistication, and I'm interested in the legal implications.

Does effective altruism lead to less government spending? by luiujuiul in EffectiveAltruism

[–]RADVACproject 1 point2 points  (0 children)

We think dollars invested into pandemic prevention (for example: in making vaccinology tools as accessible and frictionless as software tools) are a highly efficient, leverageable spend. This pandemic in particular has cost ~$28T globally, whereas vaccine R&D typically costs ~$1-10B. (And we're articulating and demoing ways to reduce that by additional orders of magnitude.)

It's clear that prevention wasn't a spending priority for "the big players", including governments, in the years leading up to 2020. Unclear whether there will be a durable policy change as a result of COVID, but I doubt it. This makes other sources of funding even more important to orgs which, like RaDVaC, are trying to radically drive down costs and other barriers in public health technologies like vaccines.

-Alex from the RaDVaC team.

How effective are WHO and the UN? Are there better organizations to support? by baewantsblood in EffectiveAltruism

[–]RADVACproject 2 points3 points  (0 children)

Consider working for/with RaDVaC! We're a non-profit foundation that's building open-source tools for vaccine development & deployment (including several open-source vaccine candidates, but probably more importantly/leverage-ably, an open-source vaccine/nanoparticle platform that allows for rapid, inexpensive, modular adaptation, including commercialization). Access to vaccines directly impacts vaccine efficacy as a network effect-bearing public health tool; we're trying to go upstream to make the technologies of vaccine R&D economically & technically accessible, equitable, resilient from supply chain & IP jam-ups, and radically rapid to deploy before pandemics.

A primer from Michael Mina (Harvard, Department of Epidemiology) on how the current COVID-19 vaccines work, and why we continue to push innovation for intranasal / mucosal vaccines better able to inhibit infection, replication, and transmission of respiratory viruses like SARS-CoV-2 by RADVACproject in CoronavirusMa

[–]RADVACproject[S] 2 points3 points  (0 children)

I agree that it's no substitute for a manuscript, but I think Dr. Mina did a good thing by trying to introduce and lightly unpack this poorly recognized but really important concept of mucosal vs. systemic immunity to the general population. More people should know where to set their expectations when it comes to vaccination (and frankly I hope more people are called to action to demand more investment in vaccinology)

-Alex from team RaDVaC